🇺🇸 FDA

Drug profile · INN

cellulose sodium phosphate

CALCIBIND

approved
US status
approved
Patents linked
6
News articles
0

Quick answer

cellulose sodium phosphate (CALCIBIND) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN cellulose sodium phosphate
Brand CALCIBIND
Route ORAL
Formulation POWDER

Related patents

Search patents →

  1. US 12187769

    Cell

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11701386

    Cell

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11643453

    Cell

    Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11365262

    Cell

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10174099

    Cell

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10098926

    Cell

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is cellulose sodium phosphate?

cellulose sodium phosphate (CALCIBIND) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for cellulose sodium phosphate?

CALCIBIND is a marketed brand name for cellulose sodium phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of cellulose sodium phosphate?

cellulose sodium phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.